| Effect of fecal microbiota transplant on symptoms of psychiatric disorders: a systematic review A Chinna Meyyappan, E Forth, CJK Wallace, R Milev BMC psychiatry 20, 1-19, 2020 | 177 | 2020 |
| Efficacy and acceptability of cannabinoids for anxiety disorders in adults: A systematic review & meta-analysis A Bahji, AC Meyyappan, ER Hawken Journal of psychiatric research 129, 257-264, 2020 | 38 | 2020 |
| Cannabinoids for the neuropsychiatric symptoms of dementia: a systematic review and meta-analysis A Bahji, AC Meyyappan, ER Hawken The Canadian Journal of Psychiatry 65 (6), 365-376, 2020 | 36 | 2020 |
| Pharmacotherapies for cannabis use disorder: A systematic review and network meta-analysis A Bahji, AC Meyyappan, ER Hawken, PG Tibbo International Journal of Drug Policy 97, 103295, 2021 | 27 | 2021 |
| The safety, efficacy, and tolerability of microbial ecosystem therapeutic-2 in people with major depression and/or generalized anxiety disorder: protocol for a phase 1, open … AC Meyyappan, R Milev JMIR Research Protocols 9 (6), e17223, 2020 | 15 | 2020 |
| Systematic review of probiotics as an adjuvant treatment for psychiatric disorders E Forth, B Buehner, A Storer, C Sgarbossa, R Milev, ... Frontiers in behavioral neuroscience 17, 1111349, 2023 | 13 | 2023 |
| Microbial ecosystem therapeutic-2 intervention in people with major depressive disorder and generalized anxiety disorder: Phase 1, Open-Label Study AC Meyyappan, E Forth, R Milev Interactive Journal of Medical Research 11 (1), e32234, 2022 | 11 | 2022 |
| The safety and efficacy of microbial ecosystem therapeutic-2 in people with major depression: protocol for a phase 2, double-blind, placebo-controlled study AC Meyyappan, C Sgarbossa, G Vazquez, DJ Bond, DJ Müller, R Milev JMIR Research Protocols 10 (9), e31439, 2021 | 9 | 2021 |
| A phase 2, double-blind, placeco-controlled study of the safety and efficacy of microbial ecosystem Therapeutic-2 (MET-2) in patients with major depression: Protocol and … AC Meyyappan, R Milev Journal of the Neurological Sciences 429, 2021 | 1 | 2021 |
| The Safety, Efficacy, and Tolerability of Microbial Ecosystem Therapeutic-2 in People With Major Depressive Disorder and/or Generalized Anxiety Disorder: A Phase 1, Open-Label … AC Meyyappan, E Forth, R Milev | 1 | 2021 |
| Probiotics as Adjuvant Treatment for Psychiatric Disorders: A Systematic Review EA Forth, B Buehner, A Storer, C Sgarbossa, R Milev, AC Meyyappan European Psychiatry 66 (S1), S242-S243, 2023 | | 2023 |
| The gut-brain axis and microbial therapeutics: The future of personalized medicine for psychiatric disorders AC Meyyappan Health Science Inquiry 11 (1), 127-130, 2020 | | 2020 |
| The safety, efficacy, and tolerability of a microbial therapeutic in people with major depression and/or generalized anxiety disorder: Preliminary findings. AC Meyyappan, R Milev European Psychiatry 63, 2020 | | 2020 |
| Examining vagal tone as a mechanism in gut-brain communication in major depressive disorder. E Forth, R Milev, AC Meyyappan, E Hawken, C Wallace European Psychiatry 63, 2020 | | 2020 |
| STI-gma: Stigma and Sexually Transmitted Infections AC Meyyappan | | |
Roumen V MilevProfessor of Psychiatry and Psychology, Queen's University, Providence Care, Kingston, On, CanadaVerified email at queensu.ca
